enocitabine has been researched along with Red-Cell Aplasia, Pure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Aoki, Y; Hanada, T; Nagasawa, T; Nakazawa, M; Ninomiya, H; Shibuya, A | 1 |
1 other study(ies) available for enocitabine and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Immunological erythroblastopenia induced by HCO-60 as a solvent of enocitabine (BH-AC).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Castor Oil; Cytarabine; Erythroblasts; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Male; Red-Cell Aplasia, Pure; Solvents | 1987 |